A Phase II Trial of Docetaxel and Carboplatin for First Relapsed Platinum-Sensitive Stage III and IV Advanced Ovarian Cancer or Peritoneal Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2010
At a glance
- Drugs Carboplatin; Docetaxel
- Indications Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Sep 2010 Actual end date (Mar 2006) added as reported by ClinicalTrials.gov.
- 01 Nov 2005 New trial record.